Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017

OBJECTIVE: The aim of this study was to update the data on the prevalence of anti-HDV antibodies in Cameroon. RESULTS: Antibodies against hepatitis Delta virus (Anti-HDV) were found in 16.48% (95% CI 11.46–18.77%) of 426 hepatitis B virus surface antigen positive patients in Cameroon. Remarkably, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Noubissi-Jouegouo, Laurence, Atsama, Marie Amougou, Tagnouokam-Ngoupo, Paul Alain, Monamele, Chavely Gwladys, Ngono, Laure, Njouom, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631665/
https://www.ncbi.nlm.nih.gov/pubmed/31307546
http://dx.doi.org/10.1186/s13104-019-4460-4
_version_ 1783435571057655808
author Noubissi-Jouegouo, Laurence
Atsama, Marie Amougou
Tagnouokam-Ngoupo, Paul Alain
Monamele, Chavely Gwladys
Ngono, Laure
Njouom, Richard
author_facet Noubissi-Jouegouo, Laurence
Atsama, Marie Amougou
Tagnouokam-Ngoupo, Paul Alain
Monamele, Chavely Gwladys
Ngono, Laure
Njouom, Richard
author_sort Noubissi-Jouegouo, Laurence
collection PubMed
description OBJECTIVE: The aim of this study was to update the data on the prevalence of anti-HDV antibodies in Cameroon. RESULTS: Antibodies against hepatitis Delta virus (Anti-HDV) were found in 16.48% (95% CI 11.46–18.77%) of 426 hepatitis B virus surface antigen positive patients in Cameroon. Remarkably, they were significantly higher among people over 40 years and those living in the East and South regions of Cameroon at 66.7%, 50%, and 40%, respectively. These results suggest that older age and living in areas in the dense forest may be risk factors for Hepatitis D infection.
format Online
Article
Text
id pubmed-6631665
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66316652019-07-24 Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017 Noubissi-Jouegouo, Laurence Atsama, Marie Amougou Tagnouokam-Ngoupo, Paul Alain Monamele, Chavely Gwladys Ngono, Laure Njouom, Richard BMC Res Notes Research Note OBJECTIVE: The aim of this study was to update the data on the prevalence of anti-HDV antibodies in Cameroon. RESULTS: Antibodies against hepatitis Delta virus (Anti-HDV) were found in 16.48% (95% CI 11.46–18.77%) of 426 hepatitis B virus surface antigen positive patients in Cameroon. Remarkably, they were significantly higher among people over 40 years and those living in the East and South regions of Cameroon at 66.7%, 50%, and 40%, respectively. These results suggest that older age and living in areas in the dense forest may be risk factors for Hepatitis D infection. BioMed Central 2019-07-15 /pmc/articles/PMC6631665/ /pubmed/31307546 http://dx.doi.org/10.1186/s13104-019-4460-4 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Noubissi-Jouegouo, Laurence
Atsama, Marie Amougou
Tagnouokam-Ngoupo, Paul Alain
Monamele, Chavely Gwladys
Ngono, Laure
Njouom, Richard
Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017
title Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017
title_full Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017
title_fullStr Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017
title_full_unstemmed Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017
title_short Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017
title_sort evolutionary trends in the prevalence of anti-hdv antibodies among patients positive for hbsag referred to a national laboratory in cameroon from 2012 to 2017
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631665/
https://www.ncbi.nlm.nih.gov/pubmed/31307546
http://dx.doi.org/10.1186/s13104-019-4460-4
work_keys_str_mv AT noubissijouegouolaurence evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017
AT atsamamarieamougou evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017
AT tagnouokamngoupopaulalain evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017
AT monamelechavelygwladys evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017
AT ngonolaure evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017
AT njouomrichard evolutionarytrendsintheprevalenceofantihdvantibodiesamongpatientspositiveforhbsagreferredtoanationallaboratoryincameroonfrom2012to2017

Ejemplares similares